MedTrace Logo

The Effect of Antacids and Multivitamins on Raltegravir

NCT01784302 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-02-25

No results posted yet for this study

Summary

This study seeks to address the question of whether antacids or multivitamins influence the pharmacokinetics of raltegravir when co-administered. The aim of this study is to optimise the dosing of raltegravir when co-administered with antacids or multivitamins.

Conditions

Interventions

DIETARY_SUPPLEMENT

Multivitamins

DIETARY_SUPPLEMENT

Sodium bicarbonate

DRUG

Maalox Plus extra

DRUG

Raltegravir 400 mg

Sponsors & Collaborators

  • Helen Reynolds

    lead OTHER

Principal Investigators

  • Saye Khoo, Prof · University of Liverpool

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01784302 on ClinicalTrials.gov